About Me
Dr. Dafna Gladman, Professor of Medicine, University of Toronto and Senior Scientist, Krembil Research Institute, has changed the way rheumatologists manage psoriatic arthritis (PsA). She found that PsA
is more common and more severe than previously thought. She has identified factors that lead to the development of PsA among patients with psoriasis, and factors that are associated with more severe PsA.
She also alerted the medical community to the fact that PsA was associated with important comorbidities including coronary artery disease, diabetes, obesity and depression. She has also led a number of clinical trials of new medications for PsA.